The Probi range of products increase iron absorption and support bone health through the use of probiotics.
Singapore, November 01, 2022 – DKSH Business Unit Healthcare, a leading market expansion services provider for healthcare companies seeking to grow their business in Asia and beyond, has acquired the rights to Probi AB to bring their range of probiotics to Singapore. Kicking off the launch are two of its key product offerings, Probi® Iron+ and Probi® Bone Health.
Probi AB creates probiotics for functional health benefits that extend beyond gut health. Formulated by scientists in Sweden’s Lund University since 1991, Probi AB is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. Probi AB manages stable, live bacteria from R&D through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Probi AB’s health concepts, formulations, and formats are supported by clinical studies. The company currently owns more than 400 patents globally.
The new addition of Probi® Iron+ contains the patented bacteria strain Lactobacillus plantarum 299v (LP299V®) that supports the increase in iron absorption.
Probi® Bone Health helps maintain and support bone health through a mix of three probiotic strains (Lactobacillus plantarum HEAL9™, Lactobacillus plantarum HEAL19, Lactobacillus paracasei 8700:2) and Vitamin D.
The new Probi® products include:
- Probi® Iron+: An innovative probiotic supplement to increase total iron intake, uptake, and to support iron status. It is based on patented bacteria strain Lactobacillus plantarum 299v (LP299V®), combined with iron, folic acid and Vitamin C. Multiple clinical studies have shown that LP299V® increases iron absorption and boosts intake and uptake1-3.
- Probi® Bone Health: General recommendation for bone health today are intake of calcium and vitamin D however, if calcium and vitamin D levels are adequate, additional intake will not have any beneficial effect4. Thus, differentiating Probi® Bone Health as it is a new and innovative supplement which contains three probiotic strains to support bone health. The three probiotic strains have been studied to help reduce the loss of bone mineral in postmenopausal women5 for stronger bones.
Probi® Iron+ and Probi® Bone Health retails for $49.90 each and are available in select Watsons stores, Shopee, and Redmart in Singapore.
References
1 Bering et al., 2006
A lactic acid-fermented oat gruel increases non-haem iron absorption from a phytate-rich meal in healthy women of childbearing age
https://pubmed.ncbi.nlm.nih.gov/16869994/
2 Hoppe et al., 2015
Probiotic strain Lactobacillus plantarum 299v increases iron absorption from an iron-supplemented fruit drink: a double-isotope cross-over single-blind study in women of reproductive age
https://pubmed.ncbi.nlm.nih.gov/26428277/
3 Hoppe et al., 2017
Freeze-dried Lactobacillus plantarum 299v increases iron absorption in young females-Double isotope sequential single-blind studies in menstruating women
https://pubmed.ncbi.nlm.nih.gov/29236734/
4 Tai et al., 2015
Calcium intake and bone mineral density
https://www.bmj.com/content/351/bmj.h4183
5 Jansson et al., 2019
Probiotic treatment using a mix of three Lactobacillus strains for lumbar spine bone loss in postmenopausal women
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(19)30068-2/fulltext
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution, and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,920 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2021. www.dksh.com/hec